EVH

Evolent Health, Inc. NYSE

Healthcare ·Medical - Healthcare Information Services ·US · evolenthealth.com

$3.99

After hrs $3.91 +0.00%

Mkt Cap $454.9M

52w Low $2.10 19.0% of range 52w High $12.06

50d MA $2.88 200d MA $5.54

P/E (TTM) -0.7x

EV/EBITDA -3.6x

P/B 1.0x

Debt/Equity 2.4x

ROE -103.4%

P/FCF 96.1x

RSI (14) —

ATR (14) —

Beta 0.37

50d MA $2.88

200d MA $5.54

Avg Volume 3.1M

About

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population …

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 24, 2026	AMC	0.06	0.08	+33.3%	2.56	-2.0%	+22.7%	+29.7%	+27.0%	+39.8%	+37.1%	—
Nov 6, 2025	AMC	0.10	0.05	-50.0%	6.00	+3.0%	-17.3%	-17.5%	-16.0%	-25.8%	-30.7%	—
Aug 7, 2025	AMC	0.09	-0.10	-211.1%	9.69	-13.4%	-7.1%	-4.9%	-9.2%	-7.4%	-9.0%	—
May 8, 2025	AMC	0.09	0.06	-33.3%	10.78	+3.9%	-16.0%	-13.6%	-14.0%	-17.1%	-18.2%	—
Feb 20, 2025	AMC	0.38	-0.02	-105.3%	10.71	-0.2%	-2.6%	-4.9%	-2.2%	-11.8%	-19.0%	—
Nov 7, 2024	AMC	0.30	0.04	-86.7%	24.57	-41.4%	-45.6%	-38.4%	-41.2%	-48.1%	-48.4%	—
Aug 8, 2024	AMC	0.21	0.30	+42.9%	20.87	+32.3%	+26.5%	+21.2%	+25.8%	+27.6%	+30.3%	—
May 9, 2024	AMC	0.21	0.34	+61.9%	26.96	-2.7%	-9.3%	-11.9%	-11.5%	-12.6%	-13.5%	—
Feb 22, 2024	AMC	0.11	0.23	+109.1%	29.77	+10.0%	+14.4%	+12.6%	+14.7%	+13.5%	+13.9%	—
Nov 2, 2023	AMC	0.09	0.30	+233.3%	24.01	+6.7%	+13.5%	+17.2%	+18.4%	+16.2%	+15.3%	—
Aug 2, 2023	AMC	0.09	0.14	+55.6%	29.63	-1.8%	-5.1%	+0.5%	-2.1%	-2.5%	-4.8%	—
May 3, 2023	AMC	0.15	0.21	+40.0%	35.20	-9.1%	-4.7%	-3.4%	-1.3%	-0.1%	-0.1%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Mar 2	Oppenheimer	Maintains	Outperform → Outperform	—	$3.25	$3.17	-2.5%	+10.2%	+8.0%	+9.2%	+4.6%	-2.5%
Feb 26	UBS	Maintains	Buy → Buy	—	$3.14	$3.14	+0.0%	+5.7%	+3.5%	+14.0%	+11.8%	+13.1%
Feb 26	Truist	Maintains	Buy → Buy	—	$3.14	$3.14	+0.0%	+5.7%	+3.5%	+14.0%	+11.8%	+13.1%
Feb 26	Citigroup	Maintains	Buy → Buy	—	$3.14	$3.14	+0.0%	+5.7%	+3.5%	+14.0%	+11.8%	+13.1%
Feb 25	KeyBanc Capital Markets	Downgrade	Overweight → Sector Weight	—	$2.56	$2.51	-2.0%	+22.7%	+29.7%	+27.0%	+39.8%	+37.1%
Feb 25	Needham	Maintains	Buy → Buy	—	$2.56	$2.51	-2.0%	+22.7%	+29.7%	+27.0%	+39.8%	+37.1%
Feb 25	BTIG	Maintains	Buy → Buy	—	$2.56	$2.51	-2.0%	+22.7%	+29.7%	+27.0%	+39.8%	+37.1%
Feb 25	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$2.56	$2.51	-2.0%	+22.7%	+29.7%	+27.0%	+39.8%	+37.1%
Feb 2	BTIG	Maintains	Buy → Buy	—	$3.21	$3.18	-0.9%	+1.6%	-3.7%	-4.7%	-10.0%	-11.2%
Jan 9	Citigroup	Maintains	Buy → Buy	—	$4.16	$4.17	+0.2%	+0.2%	-0.2%	-3.6%	-6.2%	-5.3%
Jan 6	Citizens	Maintains	Market Outperform → Market Outperform	—	$3.95	$3.93	-0.5%	+1.8%	+5.1%	+5.3%	+5.6%	+5.1%
Nov 21	Citigroup	Maintains	Buy → Buy	—	$3.69	$3.67	-0.5%	+12.2%	+15.7%	+16.8%	+13.8%	+13.8%
Nov 17	JP Morgan	Maintains	Overweight → Overweight	—	$4.18	$4.10	-1.9%	-7.4%	-4.3%	-15.3%	-11.7%	-1.0%
Nov 14	Canaccord Genuity	Maintains	Buy → Buy	—	$4.16	$4.03	-3.1%	+0.5%	-7.0%	-3.8%	-14.9%	-11.3%
Nov 12	Oppenheimer	Maintains	Outperform → Outperform	—	$5.04	$5.05	+0.2%	-11.7%	-17.5%	-17.1%	-23.2%	-20.6%
Nov 10	Truist	Maintains	Buy → Buy	—	$4.96	$5.01	+1.0%	-0.2%	+1.6%	-10.3%	-16.1%	-15.7%
Nov 10	Citizens	Maintains	Market Outperform → Market Outperform	—	$4.96	$5.01	+1.0%	-0.2%	+1.6%	-10.3%	-16.1%	-15.7%
Nov 7	BTIG	Maintains	Buy → Buy	—	$6.00	$6.18	+3.0%	-17.3%	-17.5%	-16.0%	-25.8%	-30.7%
Sep 30	BTIG	Maintains	Buy → Buy	—	$8.77	$8.76	-0.1%	-3.5%	-8.4%	-10.0%	-6.2%	-5.9%
Sep 24	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$8.39	$8.49	+1.2%	+14.5%	+6.3%	+6.7%	+4.5%	+0.8%
Sep 9	BTIG	Maintains	Buy → Buy	—	$9.67	$9.82	+1.6%	+3.3%	-5.0%	-3.7%	-6.7%	-10.9%
Sep 9	Canaccord Genuity	Maintains	Buy → Buy	—	$9.67	$9.82	+1.6%	+3.3%	-5.0%	-3.7%	-6.7%	-10.9%
Aug 28	Piper Sandler	Maintains	Overweight → Overweight	—	$9.62	$9.91	+3.0%	+0.2%	+0.3%	-0.1%	-0.4%	-1.4%
Jul 17	Truist	Maintains	Buy → Buy	—	$11.44	$11.71	+2.4%	-1.5%	-16.7%	-14.7%	-14.6%	-10.8%
Jun 20	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$8.65	$8.89	+2.8%	+6.9%	+21.4%	+22.8%	+23.8%	+24.3%
May 13	Needham	Maintains	Buy → Buy	—	$9.31	$9.22	-1.0%	-0.4%	-4.0%	-5.3%	-5.2%	-7.4%
May 9	UBS	Maintains	Buy → Buy	—	$10.78	$11.20	+3.9%	-16.0%	-13.6%	-14.0%	-17.1%	-18.2%
Apr 28	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$8.98	$9.04	+0.7%	+4.0%	+9.6%	+9.8%	+10.8%	+19.0%
Apr 10	Truist	Maintains	Buy → Buy	—	$10.00	$9.83	-1.7%	-1.1%	+0.3%	-2.1%	-7.1%	-7.7%
Mar 10	JP Morgan	Maintains	Overweight → Overweight	—	$8.99	$9.49	+5.6%	+1.2%	+4.4%	+5.5%	+6.1%	+4.7%
Feb 24	Citizens Capital Markets	Maintains	Market Outperform → Market Outperform	—	$10.43	$10.44	+0.1%	-2.4%	+0.4%	-9.4%	-16.8%	-13.8%
Feb 21	Needham	Maintains	Buy → Buy	—	$10.71	$10.69	-0.2%	-2.6%	-4.9%	-2.2%	-11.8%	-19.0%
Feb 21	Piper Sandler	Maintains	Overweight → Overweight	—	$10.71	$10.69	-0.2%	-2.6%	-4.9%	-2.2%	-11.8%	-19.0%
Feb 14	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$9.97	$10.02	+0.5%	+0.5%	+1.5%	+5.5%	+7.4%	+4.6%
Feb 12	Needham	Maintains	Buy → Buy	—	$9.86	$9.66	-2.0%	-2.6%	+1.1%	+1.6%	+2.6%	+6.7%
Jan 28	JP Morgan	Maintains	Overweight → Overweight	—	$9.98	$10.04	+0.6%	+4.4%	+4.3%	+6.0%	+4.7%	+2.3%
Jan 24	Oppenheimer	Maintains	Outperform → Outperform	—	$10.18	$9.97	-2.1%	-0.8%	-2.0%	+2.4%	+2.3%	+3.9%
Jan 24	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$10.18	$9.97	-2.1%	-0.8%	-2.0%	+2.4%	+2.3%	+3.9%
Jan 23	Canaccord Genuity	Maintains	Buy → Buy	—	$10.00	$10.04	+0.4%	+1.8%	+1.0%	-0.2%	+4.2%	+4.1%
Jan 22	Truist	Maintains	Buy → Buy	—	$10.17	$10.10	-0.7%	-1.7%	+0.1%	-0.7%	-1.9%	+2.5%
Jan 21	Stephens & Co.	Maintains	Equal Weight → Equal Weight	—	$10.00	$10.04	+0.4%	+1.7%	+0.0%	+1.8%	+1.0%	-0.2%
Jan 16	UBS	Maintains	Buy → Buy	—	$9.97	$9.96	-0.1%	+1.9%	+0.3%	+2.0%	+0.3%	+2.1%
Jan 15	Needham	Maintains	Buy → Buy	—	$11.18	$11.40	+2.0%	-10.8%	-9.1%	-10.6%	-9.0%	-10.6%
Jan 14	RBC Capital	Maintains	Outperform → Outperform	—	$12.39	$12.70	+2.5%	-9.8%	-19.5%	-18.0%	-19.3%	-17.9%
Jan 13	Truist	Maintains	Buy → Buy	—	$12.54	$12.40	-1.1%	-1.2%	-10.8%	-20.5%	-19.0%	-20.3%
Jan 10	Citigroup	Maintains	Buy → Buy	—	$12.60	$12.41	-1.5%	-0.5%	-1.7%	-11.3%	-20.9%	-19.4%
Jan 10	JMP Securities	Maintains	Market Outperform → Market Outperform	—	$12.60	$12.41	-1.5%	-0.5%	-1.7%	-11.3%	-20.9%	-19.4%
Nov 22	JP Morgan	Maintains	Overweight → Overweight	—	$11.59	$11.61	+0.2%	-2.9%	+5.3%	+14.4%	+11.6%	+11.5%
Nov 18	Oppenheimer	Maintains	Outperform → Outperform	—	$12.38	$12.26	-1.0%	-0.2%	-3.5%	-8.6%	-6.4%	-9.1%
Nov 13	Citigroup	Maintains	Buy → Buy	—	$14.44	$14.53	+0.6%	-11.7%	-12.3%	-14.3%	-14.5%	-17.2%

Recent Filings

8-K

Evolent Health, Inc -- 8-K Filing

Evolent Health reported Q4 2025 results, showing the company's performance in managing complex healthcare conditions through its simplified care delivery model.

Feb 24

Data updated apr 25, 2026 7:59am · Source: massive.com